Detection of pancreatic beta cell DNA in the circulation of patients with type 1 diabetes using the dual Amplification Refractory Mutation System PCR
Not Applicable
Recruiting
- Conditions
- type 1 diabetes, pancreas transplantation, islet transplantation
- Registration Number
- JPRN-UMIN000033501
- Lead Sponsor
- Diabetes Therapeutics and Research Center Institute of Advanced Medical Sciences, Tokushima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 370
Inclusion Criteria
Not provided
Exclusion Criteria
Any condition which, in the opinion of the investigator, would compromise the ability to meet protocol requirements.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does dual ARMS PCR detect pancreatic beta cell DNA in type 1 diabetes patients' circulation?
What role do beta cell DNA biomarkers play in monitoring islet or pancreas transplant outcomes?
Can circulating beta cell DNA levels predict autoimmune response or graft failure in T1D transplants?
How does beta cell DNA detection via ARMS PCR compare to standard C-peptide or autoantibody assays in T1D?
What molecular pathways are implicated in beta cell DNA release in type 1 diabetes post-transplantation?